安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Eikon Therapeutics
Advancing breakthrough therapeutics through the purposeful integration of science and engineering
- Eikon Therapeutics Announces Business Update Highlighting Pipeline and . . .
Separately, in collaboration with Impact Therapeutics, Eikon is advancing IMP1734, a novel, highly potent, PARP1 inhibitor that shows profound biochemical and cellular selectivity versus PARP2, a related enzyme that is thought to contribute disproportionately to the adverse effect profiles of currently marketed PARP1 2 inhibitors
- Eikon Therapeutics
Eikon Therapeutics Secures $350 7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline HAYWARD, Calif – February 26, 2025 – Eikon Therapeutics, Inc , a pivotal-stage biotechnology company that integrates advanced engineering with cutting-edge molecular and cell biology to accelerate drug discovery and development
- Eikon Therapeutics Secures $350. 7 Million Series D to Advance Clinical . . .
Eikon’s early-stage pipeline features, among other undisclosed candidates, two androgen receptor antagonists and an internally derived WRN inhibitor (EIK1005) that is being studied for its potential as a therapy for patients with MSI-high and other DNA repair–deficient cancers
- Pipeline - Eikon Therapeutics
Eikon has a growing therapeutic pipeline with the potential to deliver important new medicines to address serious illnesses, many with severely unmet medical needs We have clinical programs that have already provided evidence of activity in the treatment of solid tumors
- Eikon Therapeutics Acquires Global Rights to Clinical-Stage Assets and . . .
As part of its agreement with Impact Therapeutics, Eikon will work to bring the IND-ready asset IMP1734, a highly selective PARP1 inhibitor, into clinical development
- Eikon Therapeutics to Provide Corporate Updates at the 42nd Annual J. P . . .
HAYWARD, Calif – JANUARY 8, 2024 – Eikon Therapeutics, Inc , a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that the company will provide an overview of clinical and preclinical progress in a presentation at the 42nd Annual J P Morgan Healthcare Conference
- About Us - Eikon Therapeutics
Advancing breakthrough therapeutics through the purposeful integration of science and engineering
|
|
|